Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Immunology | Pediatrics/Neonatology

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Timentin

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: SmithKline Beecham
Approval Status: Approved January 1998
Treatment Area: Infections in children

General Information

Timentin (disodium/clavulanate potassium) has been approved as an injectable antibiotic for use in treating a wide range of infections in children aged 3 months to 16 years. The drug was previously approved for use in adult patients.